ARDX Ardelyx Inc

Price (delayed)

$8.68

Market cap

$2.02B

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$0.3

Enterprise value

$2.05B

Ardelyx is focused on discovering, developing, and commercializing innovative first-in-class medicines to enhance the lives of patients with kidney and cardiorenal diseases. Ardelyx is advancing tenapanor, a novel product candidate ...

Highlights
The EPS has increased by 29% year-on-year
The company's revenue has surged by 139% YoY but it fell by 7% QoQ
The company's gross profit has surged by 122% YoY but it fell by 10% QoQ
The net income has plunged by 149% from the previous quarter
Ardelyx's debt has surged by 63% QoQ and by 54% YoY

Key stats

What are the main financial stats of ARDX
Market
Shares outstanding
232.69M
Market cap
$2.02B
Enterprise value
$2.05B
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
12.08
Price to sales (P/S)
15.3
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
16.51
Earnings
Revenue
$124.46M
EBIT
-$60.57M
EBITDA
-$55.65M
Free cash flow
-$90.06M
Per share
EPS
-$0.3
Free cash flow per share
-$0.41
Book value per share
$0.72
Revenue per share
$0.57
TBVPS
$1.36
Balance sheet
Total assets
$297.58M
Total liabilities
$130.76M
Debt
$55.98M
Equity
$166.82M
Working capital
$195.72M
Liquidity
Debt to equity
0.34
Current ratio
4.88
Quick ratio
4.09
Net debt/EBITDA
-0.62
Margins
EBITDA margin
-44.7%
Gross margin
85.7%
Net margin
-53.1%
Operating margin
-50.8%
Efficiency
Return on assets
-26%
Return on equity
-43.6%
Return on invested capital
-31.1%
Return on capital employed
-24.5%
Return on sales
-48.7%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

ARDX stock price

How has the Ardelyx stock price performed over time
Intraday
-1.59%
1 week
-3.98%
1 month
0.23%
1 year
182.74%
YTD
40%
QTD
40%

Financial performance

How have Ardelyx's revenue and profit performed over time
Revenue
$124.46M
Gross profit
$106.66M
Operating income
-$63.28M
Net income
-$66.07M
Gross margin
85.7%
Net margin
-53.1%
ARDX's operating margin has dropped by 195% since the previous quarter but it has surged by 58% year-on-year
The company's operating income has shrunk by 173% QoQ
Ardelyx's net margin has shrunk by 168% QoQ but it has surged by 59% YoY
The net income has plunged by 149% from the previous quarter

Growth

What is Ardelyx's growth rate over time

Valuation

What is Ardelyx stock price valuation
P/E
N/A
P/B
12.08
P/S
15.3
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
16.51
The EPS has increased by 29% year-on-year
ARDX's P/B is 195% above its 5-year quarterly average of 4.1 and 78% above its last 4 quarters average of 6.8
Ardelyx's equity has surged by 70% YoY but it has decreased by 13% QoQ
The company's revenue has surged by 139% YoY but it fell by 7% QoQ
The price to sales (P/S) is 84% lower than the 5-year quarterly average of 97.8 but 44% higher than the last 4 quarters average of 10.6

Efficiency

How efficient is Ardelyx business performance
The return on sales has dropped by 195% since the previous quarter but it has surged by 60% year-on-year
Ardelyx's ROA has plunged by 122% from the previous quarter but it has increased by 42% YoY
Ardelyx's ROE has plunged by 120% from the previous quarter but it has soared by 54% YoY
The company's return on invested capital has shrunk by 98% QoQ but it has surged by 67% YoY

Dividends

What is ARDX's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for ARDX.

Financial health

How did Ardelyx financials performed over time
ARDX's total assets is 128% greater than its total liabilities
The company's current ratio has surged by 109% YoY but it fell by 12% QoQ
The company's quick ratio has surged by 103% YoY but it fell by 15% QoQ
Ardelyx's debt is 66% lower than its equity
Ardelyx's debt to equity has surged by 89% QoQ but it has decreased by 8% YoY
Ardelyx's equity has surged by 70% YoY but it has decreased by 13% QoQ

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.